Neurocognitive Function

6

Review clinical trials related to Neurocognitive Function. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases

In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Jona Hattangadi-GluthUpdated: Jun 10, 2026Locations: 1
Eligibility criteria

Patients 18 years or older [+7]

Pregnant or nursing women [+7]

Status: Recruiting

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

Obstructive sleep apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD) are highly prevalent chronic respiratory diseases in the Veteran population. OSA co-occurring with COPD, known as Overlap Syndrome (OVS), is a complex chronic medical condition associated with grave consequences. OVS is highly prevalent in Veterans. Veterans with OVS may be at increased risk for cognitive deficits, poor sleep quality as well as a reduced quality of life (QoL). The overall objective is to study the effects of positive airway pressure therapy on clinical outcomes in patients with OVS.

Participants needed: 668
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: VA Office of Research and DevelopmentUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

OSA with moderate-to-severe disease, AHI 20 per hour by in-lab polysomnography w... [+3]

Current or prior treatment with PAP or oral appliance [+16]

Status: Recruiting

Brain Connectivity Changes in Glioma Patients During Treatment

The goal of this observational study is to better understand how the brain changes during the treatment of glioma. In particular, the study looks at changes in important brain areas that are responsible for functions such as movement, language, or sensation, as well as the nerve fiber pathways that connect these areas. The main question this study aims to answer is: How do important brain areas and their connections adapt and reorganize over the course of glioma treatment? Patients with glioma will undergo repeated brain imaging examinations as part of their regular medical care. These images will be analyzed over time to observe changes in brain activity and structure during different stages of therapy. By studying these changes, researchers hope to gain new insights into the brain's ability to adapt (neuroplasticity) throughout the entire course of glioma treatment.

Participants needed: 20
Trial details
Age: 18-64Biological sex: AllType: ObservationalSponsor: Johannes Kepler University of LinzUpdated: May 29, 2026Locations: 1
Eligibility criteria

Patients with diffuse gliomas (WHO grade 2-4). [+3]

Age <18 years or >65 years. [+11]

Status: Recruiting

Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)

This study will examine the safety and efficacy of TNX-102 SL to reduce ASR symptoms and behavioral changes among patients presenting to the emergency department (ED) after motor vehicle collision (MVC). Specifically, the investigators will perform the Optimizing Acute Stress reaction Interventions with TNX-102 SL (OASIS) Trial, a double-blind placebo-controlled randomized clinical trial (RCT) to determine if TNX-102 SL initiated in the ED in the hours after MVC to high risk individuals, treats/reduces acute stress reaction (ASR)/acute stress disorder (ASD) symptoms (primary outcome), improves neurocognitive function, and prevents/reduces posttraumatic stress (PTS) symptoms (secondary outcomes) long term. 180 participants will be randomized, receive study drug in ED and be discharged with a 2-week drug supply. Prior to initial dose of study drug administration, and during the hours, days, and weeks after participants will receive serial longitudinal assessments of psychological and somatic symptoms, neurocognitive function, and adverse events.

Participants needed: 180
Trial details
Phase: Phase 2Age: 18-55Biological sex: AllType: InterventionalSponsor: University of North Carolina, Chapel HillUpdated: Apr 13, 2026Locations: 9
Eligibility criteria

≥ 18 years and ≤ 55 years of age [+10]

Substantial comorbid injury (e.g., long bone fracture) [+18]

Status: Recruiting

taVNS + CCT for Neurocognitive Rehab

The purpose of this study is to investigate whether combining transcutaneous auricular vagus nerve stimulation (taVNS) with computerized cognitive training might help improve thinking abilities and mood. Participants will self-administer these treatment in their homes and undergo pre- and post-treatment assessments of thinking abilities and mood and brain MRIs.

Participants needed: 20
Trial details
Age: 45-80Biological sex: AllType: InterventionalSponsor: Medical University of South CarolinaUpdated: Apr 8, 2026Locations: 1
Eligibility criteria

Not listed

Status: Not yet recruiting

3-Dimensional Evaluation of Body Perception

The goal of this observational study is to evaluate the changing body perception of amputees aged 18-65 years using prostheses through different personal perspectives of the right-left distinction. In addition, we aimed to examine the relationship between possible changes in body perception and visual spatial perception and neurocognitive performances. The main questions that this study aimed to answer are as follows: 1. Is there a difference between the amputee group and the control group in terms of parameters related to body perception? 2. Is there a difference between the amputee group and the control group in terms of neurocognitive skills? 3. Is there any difference between the amputee group and the control group in terms of visual spatial perception abilities? To examine whether changes in body perception in amputees affect neurocognitive performance, visuospatial perception and perspective perception and the relationship between them will be compared with a healthy control group. The assessments to be applied to both groups can be summarised as follows: * Demographic information such as age, gender, and education level will be recorded. * Mini-mental state test will be used to assess the cognitive level. * Edinburgh Handedness Scale will be used to determine the dominant side. * Right-left discrimination and personal perspective perception will be assessed using a desktop programme. * The clock drawing test and Benton line orientation test will be used to visual spatial perception. * A computer based program called The Central Nervous System (CNS) Vital Signs Neurocognitive Test Battery will be used to asesses neurocognitive abilities.

Participants needed: 60
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Trakya UniversityUpdated: May 22, 2025Duration: 15 Days
Eligibility criteria

Acquired amputees [+9]

Individuals with congenital amputation [+12]